Medigen Biotechnology Corp. (MBC) was established in late 1999. The company upholds the vision of “Innovations for a better life” focusing on the development of new therapies for liver diseases and cancers.

MBC has now gradually developed into a comprehensive biopharmaceutical corporation with business fields covering new drug development, innovative drug discovery, molecular diagnostics, vaccine, and generic drugs.